The autism spectrum disorder (ASD) therapeutics market reached a valuation of USD 2.11 Billion in 2024, fueled by rising investments in research and development, strong government support, and active participation from pharmaceutical companies. A robust pipeline of ASD drugs across the eight major markets is further boosting growth. The market is projected to expand at a CAGR of 6.10%... https://www.expertmarketresearch.com/reports/autism-spectrum-disorder-therapeutics-market